Four Thought Financial, LLC Ionis Pharmaceuticals Inc Transaction History

Four Thought Financial, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$31.71 - $43.0 $856 - $1,161	-27 Closed	0 $0
Q4 2021 Jan 14, 2022	SELL	$25.61 - $35.1 $6,402 - $8,775	-250 Reduced 90.25%	27 $1,000
Q1 2021 Nov 12, 2021	SELL	$42.51 - $63.78 $2,040 - $3,061	-48 Reduced 14.77%	277 $12,000
Q4 2020 Nov 12, 2021	BUY	$45.3 - $60.27 $14,722 - $19,587	325 New	325 $18,000

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Four Thought Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Four Thought Financial, LLC with notifications on news.